PLX-PAD, placental-derived mesenchymal-like stromal cells for peripheral artery disease

PLX-PAD are mesenchymal-like adherent stromal cells derived from full-term placentas. The cells are expanded in the company's proprietary bioreactor system. PLX cells are immune-privileged and feature immunomodulatory properties. PLX are used to treat peripheral artery disease (PAD) and induce improvement in blood flow and tissue oxygenation and reduce pain.